1.Pathogenesis of Focal Segmental Glomerulosclerosis.
Beom Jin LIM ; Jae Won YANG ; Woo Sung DO ; Agnes B FOGO
Journal of Pathology and Translational Medicine 2016;50(6):405-410
Focal segmental glomerulosclerosis (FSGS) is characterized by focal and segmental obliteration of glomerular capillary tufts with increased matrix. FSGS is classified as collapsing, tip, cellular, perihilar and not otherwise specified variants according to the location and character of the sclerotic lesion. Primary or idiopathic FSGS is considered to be related to podocyte injury, and the pathogenesis of podocyte injury has been actively investigated. Several circulating factors affecting podocyte permeability barrier have been proposed, but not proven to cause FSGS. FSGS may also be caused by genetic alterations. These genes are mainly those regulating slit diaphragm structure, actin cytoskeleton of podocytes, and foot process structure. The mode of inheritance and age of onset are different according to the gene involved. Recently, the role of parietal epithelial cells (PECs) has been highlighted. Podocytes and PECs have common mesenchymal progenitors, therefore, PECs could be a source of podocyte repopulation after podocyte injury. Activated PECs migrate along adhesion to the glomerular tuft and may also contribute to the progression of sclerosis. Markers of activated PECs, including CD44, could be used to distinguish FSGS from minimal change disease. The pathogenesis of FSGS is very complex; however, understanding basic mechanisms of podocyte injury is important not only for basic research, but also for daily diagnostic pathology practice.
Actin Cytoskeleton
;
Age of Onset
;
Capillaries
;
Diaphragm
;
Epithelial Cells
;
Foot
;
Glomerulosclerosis, Focal Segmental*
;
Nephrosis, Lipoid
;
Pathology
;
Permeability
;
Podocytes
;
Rabeprazole
;
Sclerosis
;
Wills
2.Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance
Sung-Eun CHOI ; Agnes B. FOGO ; Beom Jin LIM
Kidney Research and Clinical Practice 2023;42(2):166-173
The National Institutes of Health (NIH) lupus nephritis activity and chronicity indices, which comprise six activity scores and four chronicity scores, have a long development history. The 2018 revised International Society of Nephrology/Renal Pathology Society classification for lupus nephritis adopted the most recent NIH indices to replace subclasses A, C, and A/C. Although an evidence-based approach should further evaluate the clinical significance of the modified NIH indices, recent validation studies demonstrated that the modified chronicity indices have a strong correlation with kidney outcome of lupus nephritis.